Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-11-23 Purchase | 2021-11-26 1:30 pm | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner | 20,000 | $2.4 | $48,000 | 3,180,465 (Indirect Direct) | View |
2021-08-17 Purchase | 2021-08-17 12:49 pm | Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director 10% Owner | 35,714 | $0 | $0 | 90,329 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-02 | Dermata Therapeutics Inc. | DRMA | Bedoya-Toro Munera Maria E SVP, Regulatory Affairs | 50,000 | $0 | 50,000 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-02 | Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, CFO | 100,000 | $0 | 100,000 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 4:06 pm | N/A 2033-01-02 | Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, CDO | 100,000 | $0 | 100,000 (Direct) | View |
2022-10-06 Option Award | 2022-10-07 5:06 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Sandler Andrew Seth Director | 10,120 | $0 | 24,184 (Direct) | View |
2022-10-06 Option Award | 2022-10-07 5:06 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Bradrick Brittany Director | 9,810 | $0 | 23,443 (Direct) | View |
2022-10-06 Option Award | 2022-10-07 5:06 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director | 30,155 | $0 | 656,554 (Direct) | View |
2022-10-06 Option Award | 2022-10-07 5:05 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | FISHER MARY Director | 9,810 | $0 | 23,443 (Direct) | View |
2022-10-06 Option Award | 2022-10-07 5:05 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director | 11,359 | $0 | 29,584 (Direct) | View |
2022-10-06 Option Award | 2022-10-07 5:05 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | WIERENGA WENDELL Director | 20,654 | $0 | 62,398 (Direct) | View |
2022-07-07 Option Award | 2022-07-08 4:10 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Sandler Andrew Seth Director | 8,874 | $0 | 14,064 (Direct) | View |
2022-07-07 Option Award | 2022-07-08 4:10 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Bradrick Brittany Director | 8,602 | $0 | 13,633 (Direct) | View |
2022-07-07 Option Award | 2022-07-08 4:10 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director | 26,441 | $0 | 312,394 (Direct) | View |
2022-07-07 Option Award | 2022-07-08 4:10 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director | 9,960 | $0 | 18,225 (Direct) | View |
2022-07-07 Option Award | 2022-07-08 4:10 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | WIERENGA WENDELL Director | 18,110 | $0 | 41,744 (Direct) | View |
2022-07-07 Option Award | 2022-07-08 4:10 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | FISHER MARY Director | 8,602 | $0 | 13,633 (Direct) | View |
2022-07-01 Option Award | 2022-07-07 8:04 pm | N/A 2032-06-30 | Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, CDO | 30,000 | $0 | 30,000 (Direct) | View |
2022-04-07 Option Award | 2022-04-08 7:26 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | WIERENGA WENDELL Director | 10,593 | $0 | 15,471 (Direct) | View |
2022-04-07 Option Award | 2022-04-08 7:19 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | FISHER MARY Director | 5,031 | $0 | 5,031 (Direct) | View |
2022-04-07 Option Award | 2022-04-08 7:17 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director | 5,826 | $0 | 8,265 (Direct) | View |
2022-04-07 Option Award | 2022-04-08 7:15 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Sandler Andrew Seth Director | 5,190 | $0 | 5,190 (Direct) | View |
2022-04-07 Option Award | 2022-04-08 7:13 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Bradrick Brittany Director | 5,031 | $0 | 5,031 (Direct) | View |
2022-04-07 Option Award | 2022-04-08 7:12 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director | 15,466 | $0 | 285,953 (Direct) | View |
2022-01-12 Option Award | 2022-01-14 5:10 pm | N/A 2032-01-11 | Dermata Therapeutics Inc. | DRMA | Bradrick Brittany Director | 10,000 | $0 | 10,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:24 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | Sandler Andrew Seth Director | 5,000 | $0 | 5,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:22 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, Development | 30,000 | $0 | 30,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:15 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, Chief Financial Officer | 30,000 | $0 | 30,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:08 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director | 5,000 | $0 | 5,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:07 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | WIERENGA WENDELL Director | 5,000 | $0 | 5,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:05 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director | 5,000 | $0 | 5,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:03 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | Mento Steven J Director | 5,000 | $0 | 5,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:01 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | FISHER MARY Director | 5,000 | $0 | 5,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 6:59 pm | N/A 2032-01-02 | Dermata Therapeutics Inc. | DRMA | Bedoya-Toro Munera Maria E Senior Vice President | 15,000 | $0 | 15,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 6:58 pm | 2022-01-03 2032-01-02 | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner | 302,127 | $0 | 302,127 (Direct) | View |
2021-09-01 Option Award | 2021-09-01 8:32 pm | N/A 2031-09-01 | Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2021-08-17 Option Award | 2021-08-17 12:52 pm | N/A 2031-08-17 | Dermata Therapeutics Inc. | DRMA | Mento Steven J Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-08-17 Conversion | 2021-08-17 12:51 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | Bedoya-Toro Munera Maria E Senior Vice President | 1,363,594 | $0 | 119,508 (Indirect) | View |
2021-08-17 Conversion | 2021-08-17 12:49 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director 10% Owner | 5,433,001 | $0 | 90,329 (Indirect) | View |